Dr. Deepak Bansal
Designation : Professor
Department : Paediatric Medicine
bansal.deepak@pgimer.edu.in

 
 
 :: Contact Details
  Phone No.    :   7087008300
  Ext No.        :   5317
 :: Educational Qualification
  Graduation :   MBBS from Maulana Azad Medical College N Delhi in year 1992
  Post Graduation :   MD from Lady Hardinge Medical College N Delhi in year 1997
  Other Qualification.(1)      :   DNB from National Board of Examinations N Delhi in year 1998
  Other Qualification.(2)      :   Fellowship Hematology Oncology from Alberta Childrens Hosp Calgary Canada in year 2009
     
 :: Area of Interest
       Area Of Interest       :
Pediatric Hematology/Oncology
     
 :: Research & Projects
      Extramural Projects       :

  • Retrospective review of high-dose methotrexate patterns of use, supportive care and outcomes. Supported by Resonance.Amplifying Health.

  • Study of treatment and outcome of chronic myeloid leukemia in children and adolescents in India. InPOG-CML-16-01. Indian Pediatric Oncology Group.

  • BRAF V600E mutation in childhood Langerhans cell histiocytosis. ICMR.Killer immunoglobulin like receptor gene polymorphism in childhood acute lymphoblastic leukemia. ICMR.

  • International Chronic Myeloid Leukemia Foundation, London, UK. Growth failure in children with chronic myeloid leukemia receiving Imatinib.

  • Prevalence of iron deficiency and iron deficiency anemia in exclusively breast fed infants (age 3-6 months) of U.T. Chandigarh region: A pilot study. Dept. of Science and Technology, Chandigarh. Deciphering the pathophysiology and etiology of undiagnosed hereditary hemolytic anemias and congenital dyserythropoietic anemias. Dept. of Biotechnology, Ministry of Science and Technology.

  • Proteomic analysis of retinoblastoma and HPV associated biological pathways. DHR-ICMR.
  • Epigenetic alterations in HPV infected and HPV non-infected retinoblastoma. Dept. of Biotechnology, Ministry of Science and Technology.
  • Detection of fusion transcripts and copy number abnormalities in pediatric B-ALL. CSIR.
  • A pilot study to screen for iron resistant iron deficiency anemia phenotype in children of U.T. Chandigarh. Department of Science and Technology, Chandigarh.
  • To study the prevalence of Herpes Simplex virus in oral mucosal lesions in children with leukemia undergoing chemotherapy, by use of a highly automated real-time polymerase chain reaction assay. Funding agency: ICMR.
  • Wilms' Tumor Gene 1 (WT1) in B-lineage Acute Lymphoblastic Leukemia: A study of its expression and utility as a prognostic and minimal residual disease marker. Department of Science and Technology (DST).
  • Analysis of red cell membrane proteins and genes involved in Hereditary spherocytosis in North Indians. Dept. of Biotechnology, Ministry of Science and Technology.
  • Effect of wheat grass juice extract on the transfusion requirement in patients with beta thalassemia major, Department of Science and Technology, Chandigarh.
      Departmental / P.G.I.
      Projects      		 :
  • Investigating the role of inhibitory NK cell receptor polymorphism in retinoblastoma.
  • Exploring microRNA signature associated with relapse in childhood B-lineage acute lymphoblastic leukemia.
  • To study the killer immunoglobulin like receptor gene polymorphism in childhood acute lymphoblastic leukemia.
  • The predictive and diagnostic value of cytokines- IL-5, IL-6, IL-8 and C-reactive protein in childhood oncology patients with febrile neutropenia.
  • Estimation of anti-L-asparaginase antibodies in children on treatment for acute lymphoblastic leukemia.
  • Treatment of chronic hepatitis C virus infection with interferon alfa and ribavarin in patients with transfusion dependent thalassemia.
  • Role of lamivudine in treatment of chronic hepatitis B virus infection in children treated for malignant disorders.
  • To study the expression of immune inhibitory receptor LAIR 1 in pediatric acute lymphoblastic leukemia.
  • Role of herpes virus as a causative agent of pneumonia in the patient with hematological disorders.
  • Gene expression profiling of reticulocytes inpatients with hereditary spherocytosis after depleting globin gene transcripts.
  • Comparison of 68Ga-DOTATE with 131I-MIBG to determine the clinical feasibility and potential advantage of somatostatin receptor imaging in Neuroblastoma patients.
  • Detection of oncogenic human papillomavirus and its variants in sporadic retinoblastoma.
  • A single blind randomized parallel group clinical trial to evaluate the efficacy and safety of G-CSF in pediatric patients with chemotherapy induced neutropenia.
      Area Of
      Specialization      		 :
Pediatric Hematology-Oncology
      Awards & Honours       :
  • Dr. I.C. Verma Excellence in Research Award for Young Pediatricians by the Dr. K. C Chaudhuri Foundation and the Indian Journal of Pediatrics, 2019, AIIMS, N Delhi.
  • Fellowship of the Indian Academy of Pediatrics, 2019.
  • Indian Council of Medical Research (ICMR) -Dr P N Raju Oration Award (2016), for excellence in clinical research.
  • Certificate of Appreciation by PGIMER, Chandigarh for presenting a high quality published research work on the 4th Annual Research Day of the institution, 2016.
  • Indian Council of Medical Research (ICMR) -Dr. H B Dingley Memorial Award (2011), for outstanding contribution in the field of Pediatrics.
  • Certificate of Appreciation by PGIMER, Chandigarh for presenting a high quality published research work on the 3rd Annual Research Day of the institution, 2014.
  • Certificate of appreciation awarded by the Indian Academy of Pediatrics for valuable services rendered as co-editor of E-Bulletin of Child India (2013).
  • 2nd prize, Grand Bumper quiz - Hematology. 54th Annual conference of Indian society of Hematology and Blood transfusion. Mumbai 2013.
  • Elected as Member of National Academy of Medical Sciences (India), N Delhi, October 2012.
  • Attained a score of 81% (National average: 57%) in the Pediatric hematology-oncology subspecialty in-training exam (2008), conducted by the American board of Pediatrics.
  • Chief resident (2008-09) of the Pediatric Hematology/Oncology fellowship program,University of Calgary, Canada.
  • Government of Punjab, awarded gold medal in recognition of exemplary service rendered in the field of oncology on 15th August 2005, at the state republic day function in Mansa, Punjab.
  • ‘Dr P N TanejaÂ’ award for the best paper in General Pediatrics, Indian Academy of Pediatrics, Delhi Branch, 1996.
  • ‘Shri Vijay Kumar GujralÂ’ award for the best junior resident of Kalawati Saran Children's Hospital, Lady Hardinge Medical College, 1994-95.
  • Third position in the 2nd professional M.B.B.S (Annual) examination, 1991, Maulana Azad Medical College, New Delhi and was awarded merit scholarship.
  • Distinction in Pharmacology in the 2nd professional M.B.B.S examination, 1991, Maulana Azad Medical College, New Delhi.
  • Merit scholarship by Maulana Azad Medical College on the basis of meritorious performance in the 10+2 examination conducted by CBSE Delhi.
  • Fellowship of the Indian Academy of Pediatrics, 7 Feb 2019.
      Member Of Professional
      Bodies      		 :
  • Member: International Society of Pediatric Oncology (SIOP) - Scientific Programme Advisory Committee: MyeloidLeukemias, Myelodysplastic and Myeloproliferative Syndromes. 2018-19
  • Honorary secretary, Pediatric Hematology Oncology chapter of the Indian Academy of Pediatrics. 2017-19.
  • Executive committee member and chronic myeloproliferative disease Group Chair, Indian Pediatric Oncology Group.
  • National Academy of Medical Sciences (India), N Delhi.
  • International society of Pediatric Oncology
  • Children's Cancer and Leukaemia Group
  • Indian Academy of Pediatrics
  • Pediatric Hematology/Oncology subspecialty chapter of the Indian Academy of Pediatrics.
  • Cure4kids.
  • International Chronic Myeloid Leukemia Foundation.
  • Indian society of Hematology and Blood transfusion.
  • North west chapter of Indian society of Hematology and Transfusion medicine
  • Chandigarh chapter of the Indian Academy of Pediatrics
  • Medical Advisory Panel of Thalassemic Children Welfare Association, Chandigarh.
  • Medical advisor, Blood bank society, Chandigarh
     
 :: Publications(In Vancouver Style)

Indexed: 212                    First or *corresponding author: 73

International: 119             Citations: 2249         h-index: 24

Google scholar                  Research Gate

Chronic myeloid leukemia

  1. Totadri S, Thipparapu S, Aggarwal R, Sharma M, Naseem S, Jain R, Trehan A, Malhotra P, Varma N, *Bansal D. Imatinib-Induced Hypogammaglobulinemia in Children and Adolescents with Chronic Myeloid Leukemia. Pediatr Hematol Oncol. 2020 May 4:1-6.
  2. Bansal D. Chronic Myeloid Leukemia in Children:Challenges and Opportunities: Based on 7th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 29th Sept. 2019. Indian J Pediatr. 2020;87:443-450.
  3. Walia R, Aggarwal A, Bhansali A, Aggarwal A, Varma N, Sachdeva N, Khandelwal N, Bansal D. Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia. Pediatr Hematol Oncol. 2020;37:99-108.
  4. Suttorp M, Metzler M, Millot F, Shimada H, Bansal D, Günes AM, Kalwak K,Sedlacek P, Baruchel A, Biondi A, Hijiya N, Schultz KR, Schrappe M. Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients. Pediatr Blood Cancer. 2018;65:e27431.

  5. Tahlan A, Varma N, NaseemS, Bansal D, Binota J, Sood A, Sachdeva MUS, Malhotra P, Varma S. ComparativeStudy of Clinico-hematological Features. Molecular Spectrum and Response toImatinib in Chronic Myelogenous Leukemia Patients: Pediatric and Adolescent VersusAdults. Indian J Hematol Blood Transfus. 2018;34:19-24.

  6. Bansal D, Shava U, Varma N, Trehan A, Marwaha RK. Imatinib has adverse effect on growth in children with Chronic Myeloid Leukemia. Pediatr Blood Cancer 2012;59:481-4.

  7. Narayanan KR, *Bansal D, Walia R, Sachdeva N, Bhansali A, Varma N, Marwaha RK. Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis. Pediatr Blood Cancer 2013;60:1148-53.
  8. Kumar S, *Bansal D, Prakash M, Sharma P. Avascular Necrosis of Femoral Head as the Initial Manifestation of CML. Pediatr Hematol Oncol 2014;31:568-73.

ITP, bleeding disorders

  1. Singh G, Bansal D, Wright NAM. Immune Thrombocytopenia in Children: Consensus and Controversies. Indian J Pediatr. 2020;87:150-157.
  2. Bansal D, Lal A. Taking Stock of Hemophilia, Immune Thrombocytopenia, and Bone Marrow Failure. Indian J Pediatr. 2020;87:132-133.
  3. Sahoo T, Naseem S, Ahluwalia J, Marwaha RK, Trehan A, *Bansal D. Inherited Bleeding Disorders in North Indian Children: 14 yearsÂ’ Experience from a Tertiary Care Center. Indian J Hematol Blood Transfus 2020;36:330-336.
  4. Virk H, Jain R, Kumar N, Uppal V, Bose SK, Bansal D, Ahluwalia J. Varying test results: A clue to pediatric acquired von Willebrand syndrome. Pediatr Blood Cancer. 2019;66:e27651.
  5. *Bansal D, Totadri S. Comprehensive Hemophilia Management in India - Miles to Go Before We Sleep. Indian Pediatr. 2018;55:559-560.
  6. Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha RK. Outcome of chronic idiopathic thrombocytopenic purpura in children. Pediatr Blood Cancer 2010;54:403-7.
  7. Bansal D. Childhood chronic ITP. Pediatr Blood Cancer 2011;56:875.
  8. Bansal D, Rajendran A, Singhi S. Newly Diagnosed ITP: Update on Diagnosis and Management. Indian J Pediatr. 2014;81:1033-41.
  9. Bansal D, Oberoi S, Marwaha RK, Singhi SC. Approach to a Child with Bleeding in the Emergency Room. Indian J Pediatr. 2013;80:411-20.
  10. Rajendran A, *Bansal D. ITP: The Dilemma of Treatment. J Pediatr Hematol Oncol 2014;36:666.

Histiocytic disorders

  1. Kapatia G,  Bhatia P,  Singh  M, Jain  R,  Bansal D,  Gupta  K. Multisystemic pediatric langerhans  cell  histiocytosis:  a comprehensive clinico-pathological  and  BRAF V600E  mutation  study at  autopsy. Autops Case Rep [Internet]. xxxx xxx.-xxx.;00(00):e2020154.
  2. Parajuli B,Angurana SK, Awasthi P, Nallasamy K, Baranwal A, Bansal A, Bansal D, Rawat A,Varma N, Jayashree M. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality. Pediatr Crit Care Med. 2020 Oct 8.
  3. Bhatia P, SinghM, Sharma M, Sharma A, Kakkar N, Radhika S, Trehan A, Bansal D*. BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival. Blood Cells Mol Dis. 2020;82:102356.
  4. Chatterjee D, Vishwajeet V, Saikia UN, Radotra B, De D, Bansal D. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells. Am J Dermatopathol.2019;41:188-192.
  5. Totadri S, Bansal D, Trehan A, Srinivasan R, Varma N, Kakkar N, Saxena AK, Bhatia P. The Five-Year EFS of Multisystem LCH With Risk-Organ Involvement Is Suboptimal: A Single-Center Experience From India. J Pediatr Hematol Oncol. 2016; 38:e1-5.
  6. Bansal D, Marwaha RK, Trehan A, Gupta V, Varma N. Langerhans' cell histiocytosis: experience from a single center. Indian Pediatr 2008;45:685-8.
  7. Bansal D, Marwaha RK, Trehan A, Poddar U, Radotra BD. Portal hypertension secondary to Langerhans cell histiocytosis. Ind J Gastroenterol 2001; 20:201-202.
  8. Goyal R, Das A, Nijhawan R, Bansal D, Marwaha RK. Langerhans cell histiocytosis infiltration into pancreas and kidney. Pediatr Blood Cancer 2007;49:748-50.
  9. Verma S, Jondhale S, Bansal D, Radotra BD, Singhi SC. Iodopovidone Pleurodesis for Isolated Pulmonary Langerhan's Cell Histiocytosis in a Two Year Old Child. Indian J Pediatr. 2014;81:715-8.
  10. Savardekar A, Tripathi M, Bansal D, Vaiphei K,Gupta SK. Isolated tumorous Langerhans cell histiocytosis of the brainstem: a diagnostic and therapeutic challenge. J Neurosurg Pediatr. 2013;12:258-61.
  11. Macartney CA, Weitzman S, Wood SM, Bansal D, Steele M, Meeths M, Abdelhaleem M, Bryceson YT. Unusual functional manifestations of a novel STX11 frameshift mutation in two infants with familial hemophagocytic lymphohistiocytosis type 4 (FHL4). Pediatr Blood Cancer 2011;56:654-7.

Thalassemia

  1. Shrestha O, Khadwal AR, Singhal M, Trehan A, Bansal D, Jain R, Pal A, Hira JK, Chhabra S, Malhotra P, Das R, Sharma P. A high frequency of Gilbert syndrome(UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult north Indian patients with transfusion-dependent β-thalassemia [published online ahead of print, 2020 Jul 16]. Ann Hematol.2020;10.
  2. Bansal D, Lal A. Iron Metabolism, Hemolytic Anemia, and Thalassemia. Indian J Pediatr. 2020;87:56-57.

  3. Lal A, Bansal D. Thalassemia: Common Clinical Queries in Management. Indian J Pediatr.2020;87:75-81.

  4. Ramamoorthy J, Trehan A,Ahluwalia J, Singh P, Manoj R, Bansal D. Neuroimaging Abnormalities in Patients With Non transfusion-dependent Thalassemia. J Pediatr Hematol Oncol.2019;41:e290-e295.

  5. Totadri S, *Bansal D, Trehan A, Khadwal A, Bhatia A, Sodhi KS, Bhatia P, Jain R, Das R, Khandelwal N. Hepatic and Cardiac Iron-load in Children on Long-term Chelation with Deferiprone for Thalassemia Major. Indian Pediatr. 2018;55:573-575.

  6. Bansal D. Financial Burden of Treatment of Transfusion Dependent Thalassemia. Indian J Pediatr.2018;85:85-86.

  7. Bansal D. Hepcidin and Thalassemia. Indian J Pediatr. 2017; 84:731-732.

  8. Mandal S, Sodhi KS, Bansal D, Sinha A, Bhatia A, Trehan A, Khandelwal N. MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population. Indian J Pediatr. 2017;84:276-282.
  9. Bansal D. Splenectomy for β-Thalassemia Major in Resource Challenged Settings: Often a Hobson's Choice! Indian J Pediatr. 2015;82:1082-3.
  10. Sreedharanunni S, Chhabra S, Hira JK, Bansal D, Sharma P, Das R. Thalassemia intermedia caused by compound heterozygosity for Hb Lepore Hollandia and β-thalassemia is rare in Indians. Hemoglobin 2015;39:362-5.
  11. Totadri S, *Bansal D, Bhatia P, Attri SV, Trehan A, Marwaha RK. The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study. Pediatr Blood Cancer 2015; 62:1592-6.
  12. Dhawan HK, Kumawat V, Marwaha N, Sharma RR, Sachdev S, Bansal D, Marwaha RK, Arora S. Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients. Asian J Transfus Sci. 2014;8:84-8.
  13. Bansal D, Venkateshwaran S, Khandelwal N, Marwaha RK. Quantitative computed tomography is unreliable for measurement of bone mineral density in inadequately chelated patients with ß-thalassemia major: A prospective, case-control study. Pediatr Blood Cancer 2011;56:409-12.
  14. Oberoi S, *Bansal D, Singh P, Marwaha RK. Stroke in a Young Boy With beta-Thalassemia Intermedia Secondary to Moyamoya Syndrome. J Pediatr Hematol Oncol 2010;32:568-70.
  15. Trehan A, Sharma N, Das R, Bansal D, Marwaha RK. Clinico investigational and Demographic Profile of Children with Thalassemia Major. Indian J Hematol Blood Transfus.2015;31:121-6.
  16. Sharma P, Das R,Trehan A, Bansal D, Chhabra S, Kaur J, Marwaha RK, Varma N,  Garewal G. Impact of iron deficiency on hemoglobin A2% in obligate b-thalassemia heterozygotes. Int J Lab Hematol. 2015;37:105-11.
  17. PanigrahiI, Vaidya PC, Bansal D, Marwaha RK. Efficacy of Deferasirox in North Indian β-Thalassemia Major Patients: A Preliminary Report. J Pediatr Hematol Oncol 2012;34: 51–53.
  18. Ahuja S, Grover G, Jha AK, Sodhi K, Bansal D, Dey P. Extramedullary hematopoiesis presented as solitary renal mass: A case report with review of literature. Diagn Cytopathol 2011;39:435-7.
  19. Marwaha RK, Bansal D, Kaur S, Trehan A.Wheat grass juice reduces transfusion requirement in patients with thalassemia major: A pilot study. Indian Pediatr 2004; 41:716-720.
  20. Marwaha RK, Bansal D. Natural antioxidant therapy for patients with hemolytic anemia-reply. Indian Pediatr 2005; 42:620.
  21. Marwaha RK, Bansal D, Sharma S, Kumar S, Trehan A, Duseja A, Chawla YK. Seroprevalence of hepatitis C and B virus in multiply transfused beta-thalassemics: results from a thalassemic day care unit in north India. Vox Sang 2003; 85:119-20.
  22. Sharma N, Das R, Kaur J, Ahluwalia J, Trehan A, Bansal D, Panigrahi I, Marwaha RK. Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with Thalassemia major. Eur J Haematol 2010;84:531-7.

Other hemolytic anemiaÂ’s (Hereditary spherocytosis, CDA, etc.)

  1. Jamwal M, Aggarwal A,Sharma P, Bansal D, Das R. Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant. Ann Hematol. 2020 Mar 27. [Epub ahead of print]
  2. Jamwal M, Aggarwal A, Palodhi A, Sharma P, Bansal D, Trehan A, Malhotra P, Maitra A, Das R.Next-generation sequencing-based diagnosis of unexplained inherited hemolyticanemias reveals wide genetic and phenotypic heterogeneity. J Mol Diagn.2020;22:579-590.

  3. Jamwal M, Aggarwal A,Sharma P, Bansal D, Maitra A, Das R. Phenotypic and genetic heterogeneity arising from a novel substitution at amino acid position Val205 in GATA1related X-linked thrombocytopenia with dyserythropoietic anemia. Blood Cells Mol Dis. 2019 Nov 30;81:102391.

  4. Aggarwal A, Jamwal M,Sharma P, Sachdeva MUS, Bansal D, Malhotra P, Das R. Deciphering molecularheterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study. Br J Haematol. 2020;188:784-795.

  5. Jamwal M, Aggarwal A,Palodi A, Sharma P, Bansal D, Maitra A, Das R. A nonsense variant in the Hexokinase 1 gene (HK1) causing severe non-spherocytic haemolytic anaemia:genetic analysis exemplifies ambiguity due to multiple Isoforms. Br J Haematol.2019;186:e142-e145.

  6. Gupta O, Chhabra S, Kaur J, Das R, Bansal D, Malhotra P, Sharma P. Unusual C- and A2-Window Peaks (Hemoglobin M-Saskatoon) in Three North Indian Patients. Indian J Hematol Blood Transfus. 2019;35:196-198.

  7. Aggarwal A, Jamwal M, Ganesh Kumar V, Sharma P, Sachdeva MUS, Bansal D, Malhotra P, Das R. Optimal Reference Gene Selection for Expression Studies in Human Reticulocytes. J Mol Diagn. 2018;20:326-333.

  8. Jamwal M, Aggarwal A, Maitra A,Sharma P, Bansal D, Trehan A, Thapa BR, Malhotra P, Das R. First report of Mediterranean stomatocytosis/macrothrombocytopenia in an Indian family: adiagnostic dilemma. Pathology.2017;49:811-815.

  9. Das A, *Bansal D, Trehan A, Das R. Growth Failure in Hereditary Spherocytosis and the Effect of Splenectomy. Indian Pediatr. 2017;54:563-566.

  10. Jamwal M, Aggarwal A, Das A, Maitra A, Sharma P, Krishnan S, Arora N, Bansal D, Das R. Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A(p.Arg347His) causing hemolysis in an Indian infant. Clin Chim Acta.2017;468:81-84.
  11. Joshi P, Aggarwal A, Jamwal M, Sachdeva MU, Bansal D, Malhotra P, Sharma P, Das R. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis. Int J Lab Hematol. 2016;38:520-6.
  12. Jamwal M, Aggarwal A, Kumar V, Sharma P, Sachdeva MU, Bansal D, Malhotra P, Das R. Disease-Modifying Influences of Coexistent G6PD-Deficiency, Gilbert Syndrome and Deletional Alpha Thalassemia in Hereditary Spherocytosis: A Report of Three Cases. Clin Chim Acta. 2016;458:51-4.
  13. Singleton B, Bansal D, Varma N, Das R, Naseem S, Saikia UN, Malhotra P, Varma S, Marwaha RK, King MJ, Ahmed M. Homozygosity mapping reveals founder SEC23B-Y462C mutations in Indian congenital dyserythropoietic anemia type II. Clin Genet. 2015;88:195-7.
  14. Das A, *Bansal D, Ahluwalia J, Das R, Rohit MK, Attri SV, Trehan A, Marwaha RK. Risk factors for thromboembolism and pulmonary artery hypertension following splenectomy in children with hereditary spherocytosis. Pediatr Blood Cancer 2014;61:29-33.
  15. Das A, *Bansal D, Das R, Trehan A, Marwaha RK. Hereditary Spherocytosis in Children: Profile and Post-splenectomy Outcome.Indian Pediatr 2014;51:139-41.
  16. Marwaha RK, Bansal D, Trehan A, Garewal G. Interferon therapy in congenital dyserythropoietic anemia type I/II. Pediatr Hematol Oncol 2005; 22:133-8.
  17. Marwaha RK, Bansal D, Trehan A, Garewal G, Marwaha N. Congenital dyserythropoietic anemia: Clinical and hematological profile. Indian Pediatr 2003; 40:551-555.
  18. Sharma P, Das R, Bansal D, Trehan A. Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → Gmutation, and pseudo-Gaucher cells in two siblings. Hematology. 2015;20:104-7.
  19. Oberoi S, Das R, Trehan A, Ahluwalia J, Bansal D, Malhotra P, Marwaha RK. HbSD-Punjab: Clinical and Hematological Profile of a Rare Hemoglobinopathy. J Pediatr Hematol Oncol 2014;36:e140-4.
Acute lymphoblastic leukemia

  1. Sharma P, Rana S, Sreedharanunni S, Gautam A, Sachdeva MUS, Naseem S, Varma N, Jain R, Bansal D,Trehan A. An Evaluation of a Fluorescence In Situ Hybridization Strategy Using Air-dried Blood and Bone-marrow Smears in the Risk Stratification of Pediatric B-Lineage Acute Lymphoblastic Leukemia in Resource-limited Settings. J Pediatr Hematol Oncol. [published online ahead of print, 2020 Aug 4].
  2. Bhatia P, Totadri S, Singh M, Sharma P, Trehan A, Bansal D, Jain R, Varma N, Sachdeva MS, Patra N. PEST domain NOTCH mutations confer a poor relapse free survival inpediatric T-ALL: Data from a tertiary care centre in India. Blood Cells Mol Dis. 2020;82:102419.
  3. Vijayan A, Singh M, Bansal D, Sreedharanunni S, Varma N, Sachdeva MUS, Bhatia P. iAMP21 screening by MLPA assay: Need for identification of characteristic pattern of amplification in addition to mean probe ratios to avoid false positivity. Int J Lab Hematol. 2020;42:e30-e34.
  4. Totadri S, Trehan A, Kaur A, Bansal D. Effect of socio-economic status & proximity of patient residence to hospital on survival in childhood acute lymphoblastic leukaemia. Indian J Med Res. 2019;149:26-33.
  5. Totadri S, *Bansal D. Staging of acute leukemia based on central nervous system involvement alone: Is it appropriate? Pediatr Blood Cancer. 2019;66:e27730.
  6. Khera S, Trehan A, Bhatia P, Singh M, Bansal D, Varma N. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2019; 83:341-348.
  7. Singh M, Bhatia P, Shandilya JK, Rawat A, Varma N, Sachdeva MS, Trehan A, Bansal D, Jain R, Totadri S. Low Expression of Leucocyte Associated Immunoglobulin Like Receptor-1 (LAIR-1/CD305) in a Cohort of Pediatric Acute Lymphoblastic Leukemia Cases. Asian Pac J Cancer Prev. 2018;19:3131-3135.
  8. Jinagal J, Gupta PC, Bansal D, Rajwanshi A, Ram J. Pseudohypopyon-a red flag sign ofmalignancy. Indian J Ophthalmol. 2018;66:1328-1329.
  9. Kathiravan M, Singh M, Bhatia P, Trehan A, Varma N, Sachdeva MS, Bansal D, Jain R, Naseem S. Deletion of CDKN2A/B is associated with inferior relapse free survival inpediatric B cell acute lymphoblastic leukemia. Leuk Lymphoma. 2018 Jul 3:1-9.
  10. Vaishnavi K, *Bansal D, Trehan A, Jain R, Attri SV. Improving the safety of high-dosemethotrexate for children with hematologic cancers in settings without accessto MTX levels using extended hydration and additional leucovorin. Pediatr Blood Cancer. 2018;65(12):e27241.
  11. Singh A, Bhatia P, Trehan A, Bansal D, Singh A, Bhatia A. Low spontaneous apoptosisindex at diagnosis predicts a high-risk phenotype in paediatric acute lymphoblastic leukaemia. Indian J Med Res. 2018;147:248-255.
  12. Singh M, Bhatia P, Trehan A, Varma N, Sachdeva MS, Bansal D, Jain R, Naseem S. Highfrequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction. Leuk Res.2018;66:79-84.
  13. Rastogi P, Naseem S, Bansal D, Varma N. T-Lineage Acute Lymphoblastic Leukemia with Granular Blasts. Indian J Hematol Blood Transfus. 2017;33:636-637.
  14. Trehan A, Bansal D, Varma N, Vora A. Improving outcome of acute lymphoblastic leukemia with a simplified protocol:report from a tertiary care center in north India. Pediatr Blood Cancer. 2017;64. doi: 10.1002/pbc.26281.
  15. Bommannan K, Singh Sachdeva MU, Varma N, Bose P, Bansal D. Role of Mid-induction Peripheral Blood Minimal Residual Disease Detection in Pediatric B-Lineage Acute Lymphoblastic Leukemia. Indian Pediatr. 2016;53:1065-1068.
  16. Das A, *Bansal D, Sreedharanunni S, Naseem S. Philadelphia Chromosome in an Infant with Pro-B Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2017;39(1):79-80.
  17. Mohapatra S, *Bansal D, Bhalla AK, Attri SV, Sachdeva N, Trehan A, Marwaha RK. Is there an increased risk of metabolic syndrome among childhood acute lymphoblastic leukemia survivors? A developing country experience. Pediatr Hematol Oncol. 2016;33:136-49.
  18. Totadri S, Trehan A, Srinivasan R, Bansal D, Bhatia P. Do traumatic lumbar punctures lead to greater relapses in acute lymphoblastic leukemia? Experience at a university hospital in India. Indian J Cancer. 2015;52:300-3.
  19. Trehan A, Prabhu V, Bansal D. The impact of weight for age on survival in acute lymphoblastic leukemia: Report from a tertiary care center in North India. Ind J Cancer 2015; 52: 203-206.
  20. Kumar BK, Bhatia P, Trehan A, Singh AP, Kaul D, Bansal D. DNA Ploidy and S-phase Fraction Analysis in Paediatric B-cell Acute Lymphoblastic Leukemia Cases: a Tertiary Care Centre Experience. Asian Pac J Cancer Prev 2015;16:7917-22.
  21. Bhatia P, Masih S, Varma N, Bansal D, Trehan A. High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia. Asian Pac J Cancer Prev 2015;16:6663-8.
  22. Ghatak N, Trehan A, Bansal D. Financial burden of therapy in families with a childwith acute lymphoblastic leukemia: report from north India. Support Care Cancer. 2016;24:103-8.
  23. Kumar P, Trehan A, Bhalla AK, Marwaha RK, Bansal D. Growth in Children Treated for Acute Lymphoblastic Leukemia: Single Institution Report from North India.Indian J Hematol Blood Transfus. 2016;32:39-45.
  24. Jain R, Trehan A, Singh R, Srinivasan R, Dogra M, Bansal D, Marwaha RK. Unusual Sites of Relapse in Pre-B Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2014;36:e506-8.
  25. Kaushik A, Bansal D, Khandelwal N, Trehan A, Marwaha RK. Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.Indian Pediatr. 2009; 46:245-248.
  26. Das A, *Bansal D, Kumar N. Acute Lymphoblastic Leukemia Mimicking Metabolic Bone Disease. Indian J Pediatr. 2014;81:827-8.
  27. Bhatti A, *Bansal D, Vashishta RK, Lal SB. Isolated gut relapse presenting as chronic diarrhea during maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2010;32:504-5.
  28. Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Overt testicular disease at diagnosis in childhood acute lymphoblastic leukemia: prognostic significance and role of testicular irradiation. Indian J Pediatr 2010;77:779-83.
  29. Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center in northern India. J Pediatr Hematol Oncol 2010;32:366-9.
  30. Sood S, Das R, Trehan A, Ahluwalia J, Sachdeva MU, Varma N, Bansal D, Marwaha RK. Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians. Leuk Lymphoma 2010;51:928-32.
  31. Marwaha RK, Kulkarni KP, Bansal D,Trehan A. Acute lymphoblastic leukemia masquerading as juvenile rheumatoid arthritis: diagnostic pitfall and association with survival. Ann Hematol 2010;89:249-54.
  32. Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons. Leuk Lymphoma 2010;51:261-8.
  33. Kulkarni KP, Marwaha RK, Trehan A, Bansal D. Testicular relapse in childhood acute lymphoblastic leukemia: the challenges and lessons. Indian J Cancer 2010;47:134-8.
  34. Kulkarni KP, Marwaha RK, Trehan A, Bansal D. Isolated right anterior chamber relapse in a patient of acute lymphoblastic leukemia presenting with facial nerve palsy. J Pediatr Hematol Oncol 2009;31:990.
  35. Kulkarni KP, Marwaha RK, Trehan A, Bansal D. Pattern of relapsed disease in childhood ALL: experience from a single tertiary care center in North India. Pediatr Hematol Oncol 2009;26:398-406.
  36. Kulkarni KP, Marwaha RK, Trehan A, Bansal D. Survival outcome in childhood acute lymphoblastic leukemia in India: Response.Pediatr Blood Cancer 2010; 54:179.
  37. Kulkarni KP, Marwaha RK, Trehan A, Bansal D. Survival outcome in childhood ALL: Experience from a tertiary care centre in North India. Pediatr Blood Cancer 2009; 53:168-173.
  38. Bhatia P, Binota J, Varma N, Bansal D, Trehan A, Marwaha RK, Malhotra P, Varma S. A Study on the Expression of BCR-ABL Transcript in Mixed Phenotype Acute Leukemia (MPAL) Cases Using the Reverse Transcriptase Polymerase Reaction Assay (RT-PCR) and its Correlation with Hematological Remission Status Post Initial Induction Therapy. Mediterr J Hematol Infect Dis 2012;4:e2012024.
  39. Bhatia P, Binota J, Varma N, Bansal D, Trehan A, Marwaha RK, Malhotra P, Varma S. Incidence of common chimeric fusion transcripts in B-cell acute lymphoblastic leukemia: an Indian perspective. Acta Haematol 2012;128:17-9.
  40. Sharma P, Narang V,Ahluwalia J, Sachdeva MU, Bansal D. Unusual Immunophenotypic Heterogeneity in B-Lineage ALL. J Lab Physicians 2012;4:128-9.
Lymphoma

  1. Totadri S, *Bansal D, Bal A, Menon P. Bulky Pelvic Hodgkin Lymphoma in a Prepubertal Girl. Indian J Med Paediatr Oncol. 2017;38:226-227.
  2. Thacker N, Bakhshi S, Chinnaswamy G, Vora T, Prasad M, Bansal D, Agarwala S, Kapoor G, Radhakrishnan V, Laskar S, Kaur T, Rath GK, Dhaliwal RS, Arora B. Management of Non-Hodgkin Lymphoma: ICMR Consensus Document. Indian J Pediatr. 2017;84:382-392.
  3. Radhakrishnan V, Kapoor G, Arora B, Bansal D, Vora T, Prasad M, Chinnaswamy G, Laskar S, Agarwala S, Kaur T, Rath GK, Bakhshi S. Management of Hodgkins Lymphoma: ICMR Consensus Document. Indian J Pediatr. 2017 Mar 30. [Epub ahead of print]
  4. Das A, *Bansal D, Chatterjee D, Srinivasan R, Kakkar N. Cutaneous diffuse large B-cell lymphoma in an infant. Pediatr Hematol Oncol.2016;33:438-440.
  5. Bhaker P, Das A, Rajwanshi A, Gautam U, Trehan A, Bansal D, Varma N, Srinivasan R. Precursor T-lymphoblastic lymphoma: Speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry. Cancer Cytopathol. 2015;123:557-65.
  6. Das A, Chatterjee D, Mittal BR, Mukherjee KK, Radotra B, *Bansal D. Central nervous system relapse in Hodgkin lymphoma: Successful treatment without radiotherapy. Pediatr Blood Cancer. 2016 Oct 12. [Epub ahead of print]
  7. Munikoty V, Bhatia A, Bansal D, DasA, Khandelwal N. Acquired TEF in Hodgkin Lymphoma in a Child: A Rare Clinical Association. J Pediatr Hematol Oncol. 2017 Jan 5. Epub ahead of print]
  8. Agrawal K, Mittal BR, Bansal D, Varma N, Srinivasan R, Trehan A, Manohar K, Kashyap R, Bhattacharya A, Marwaha RK. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. Ann Nucl Med 2013;27:146-51.
  9. Trehan A, Singla S, Marwaha RK, Bansal D, Srinivasan R. Hodgkin Lymphoma in Children: Experience in a Tertiary Care Centre in India. J Pediatr Hematol Oncol 2013;35:174-9.
Neuroblastoma
  1. Jain R, Hans R, Totadri S, Trehan A, Sharma RR, Menon P, Kapoor R, Saxena AK, Mittal BR, Bhatia P, Kakkar N, Srinivasan R, Rajwanshi A, Varma N, Samujh R, Marwaha N, *Bansal D. Autologous stem cell transplant for high-risk neuroblastoma: Achieving cure with low-cost adaptations. Pediatr Blood Cancer. 2020;67:e28273.
  2. Dhawan SR,Sharawat IK, Suthar R, Bansal D, et al. Ataxia as forme fruste of opsoclonus myoclonus ataxia syndrome. Ann Indian Acad Neurol 2020;23:415-417.
  3. Koshy A, Jain R, Srinivasan R, Bhatia P, Kakkar N, Rajwanshi A, Gupta N, Dey P, TrehanA, Bansal D. Cytopathological spectrum of peripheral neuroblastic tumours infine needle aspiration cytology and categorization as per International Neuroblastoma Pathology Classification. Cytopathology. 2019;30:634-643.
  4. *Bansal D, Totadri S, Chinnaswamy G, Agarwala S, Vora T, Arora B, Prasad M, Kapoor G, Radhakrishnan V, Laskar S, Kaur T, Rath GK, Bakhshi S. Management of Neuroblastoma: ICMR Consensus Document. Indian J Pediatr. 2017; 84:446-455.
  5. Jain R, Gupta K, Bhatia A, Bansal A, Bansal D. Hepatic Sinusoidal-obstruction Syndrome and Busulfan-induced Lung Injury in a Post-autologous Stem Cell Transplant Recipient. Indian Pediatr. 2017;54:765-770.
  6. Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with conventional chemotherapy in children older than one year: a 15-yearsÂ’ experience. Indian Pediatr 2008;45:135-9.
  7. Totadri S, Trehan A, Bhattacharya A, Bansal D, Attri SV, Srinivasan R. Chylothorax in children with cancer: A milky predicament. Indian J Cancer 2017;54:691-4.
  8. Singhi P, Sahu JK, Sarkar J, Bansal D. Clinical Profile and Outcome of Children With Opsoclonus-Myoclonus Syndrome. J Child Neurol. 2014;29:58-61.
  9. Menon P, Bansal D, Lyngdoh S, Gupta K, Sodhi K. Bilateral hemorrhagic cystic adrenal neuroblastoma with liver and lymph nodal metastases in an infant. J Indian Assoc Pediatr Surg 2012;17:171-3.
Wilms tumor
  1. Rahiman EA, Singh M, Bhatia P, Kakkar N, Trehan A, Bansal D. Copy Number Variations in Wilms Tumor: A Pilot Study From India. J Pediatr Hematol Oncol. 2019 Dec 16. [Epub ahead of print]
  2. Totadri S, Trehan A, Bansal D, Jain R. Sinusoidal obstruction syndrome during treatment for wilms' tumor: A life-threatening complication. Indian J Med Paediatr Oncol 2017;38:447-51.
  3. Prasad M,Vora T, Agarwala S, Laskar S, Arora B, Bansal D, Kapoor G, Chinnaswamy G, Radhakrishnan V, Kaur T, Rath GK, Bakhshi S. Management of Wilms Tumor: ICMR Consensus Document. Indian J Pediatr. 2017; 84:437-445.
  4. Kishore SS, Oberoi S, Bhattacharya A, Prasad R, Trehan A, Bansal D, Marwaha RK. Function and Size of the Residual Kidney After Treatment of Wilms Tumor. Pediatr Hematol Oncol. 2015;32:11-7.
Rhabdomyosarcoma
  1. *Bansal D, Das A, Trehan A, Kapoor R, Panda NK, Srinivasan R, Panda NK, Srinivasan R, Kakkar N, Sodhi KS, Saxena AK, Narasimha Rao KL. Pediatric Rhabdomyosarcoma in India: A Single-center Experience. Indian Pediatr. 2017; 54:735-738.
  2. Panda SP, Chinnaswamy G, Vora T, Prasad M, Bansal D, Kapoor G, Radhakrishnan V, Agarwala S, Laskar S, Arora B, Kaur T, Rath GK, Bakhshi S. Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document. Indian J Pediatr. 2017;84:393-402.
Solid tumors: Others
  1. Thirunavukkarasu B, Roy PS, Gupta K, Sekar A, Bansal D. Infantile Inflammatory MyofibroblasticTumor of Spleen. Fetal Pediatr Pathol. 2020 Oct 23;1-5.
  2. Aggarwal D, Gupta P, Chhabra P, Peters NJ, Bansal D, Srinivasan R, Kakkar N. Small cellcarcinoma of ovary, hypercalcemic type: cytologic, histopathologic and immunohistochemical landscapes of a rare case. J Pediatr Adolesc Gynecol. 2020 Aug 1: S1083-3188.
  3. Totadri S, Bansal D, Rao KLN, Jain R, Saxena AK, Kapoor R, Samujh R, Trehan A. Challenges in the managementof localized Ewing sarcoma in a developing country [published online ahead ofprint, 2020 Jun 19]. Pediatr Hematol Oncol. 2020;1-10.
  4. Agarwala S, Mitra A, Bansal D, Kapoor G, Vora T, Prasad M, Chinnaswamy G, Arora B, Radhakrishnan V, Laskar S, Kaur T, Dhaliwal RS, Rath GK, Bakhshi S. Management of Pediatric Malignant Germ Cell Tumors: ICMR Consensus Document. Indian J Pediatr. 2017; 84:465-472.
  5. Agarwala S, Gupta A, Bansal D, Vora T, Prasad M, Arora B, Kapoor G, Chinnaswamy G, Radhakrishnan V, Laskar S, Kaur T, Dhaliwal RS, Rath GK, Bakhshi S. Management of Hepatoblastoma: ICMR Consensus Document. Indian J Pediatr. 2017; 84:456-464.
  6. Gupta N, Bansal D, Saxena AK, Srinivasan R, Marwaha RK. Primary orbital Ewing's sarcoma presenting with unilateral proptosis.Cytopathology 2008;19:124-6.
  7. Gautam U, Srinivasan R, Rajwanshi A, Bansal D, Marwaha RK. Comparative evaluation of flow-cytometric immunophenotyping and immunocytochemistry in the categorization of malignant small round cell tumors in fine-needle aspiration cytologic specimens. Cancer 2008;114: 494-503.
  8. Gautam U, Srinivasan R, Rajwanshi A, Bansal D, Marwaha RK, Vasishtha RK. Reverse transcriptase-polymerase chain reaction as an ancillary molecular technique in the diagnosis of small blue round cell tumors by fine-needle aspiration cytology. Am J Clin Pathol 2010;133:633-45.
  9. Menon P, Bansal D, Rao KL. Unresectable gastrointestinal tumors. J Indian Assoc Pediatr Surg 2011;16:78-79.
  10. Arora SK, Srinivasan R, Nijhawan R, Bansal D, Menon P. Malignant biphasic peritoneal mesothelioma in a child: Fine-needle aspiration cytology, Histopathology, and immunohistochemical features along with review of literature. Diagn Cytopathol 2012;40:1112-5.
  11. Saikia UN, Gupta N, Bansal D, Saxena AK, Joshi K, Srinivasan R. Malignant fibrous histiocytoma (inflammatory variant) in a child presenting asparaparesis. Fetal Pediatr Pathol 2004; 23: 319-23.
Retinoblastoma
  1. Totadri S, Munikoty V, Singh U, Srinivasan R, Trehan A, Jain R, Kakkar N, Saxena AK, Rajwanshi A, *Bansal D. Is a diagnostic lumbar puncture indicated inintraocular retinoblastoma? Indian J Pathol Microbiol. 2018;61:201-203.
  2. Kaur S, Singh U, Gupta V, Bansal D. Comment: Intra-arterial chemotherapy for retinoblastoma. Indian J Ophthalmol. 2017;65:901-902.
  3. Singh U, Katoch D, Kaur S, Dogra M R, Bansal D. Kapoor R. Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India. Ocul Oncol Pathol 2017;4:23-32.
  4. Bhargav A, Singh U, Trehan A, Zadeng Z, *Bansal D. Female Sex, Bilateral Disease, Age Below 3 Years, and Apprehension for Enucleation Contribute to Treatment Abandonment in Retinoblastoma. J Pediatr Hematol Oncol. 2017; 39:e249-e253.
  5. Naru J, Aggarwal R, Mohanty AK, Singh U, Bansal D, Kakkar N, Agnihotri N. Identification of differentially expressed proteins in retinoblastoma tumorsusing mass spectrometry-based comparative proteomic approach. J Proteomics.2017;159:77-91.
  6. Das A, Singh U, *Bansal D. Retinoblastoma Mimicking Orbital Cellulitis.Indian Pediatr. 2016 Nov 15;53:1037.
  7. Naru J, Aggarwal R, Singh U, Mohanty AK, Bansal D, Mangat N, Kakkar N, Agnihotri N. Proteomic analysis of differentially expressed proteins in vitreous humor ofpatients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach. Tumour Biol. 2016;37:13915-13926.
  8. Naru J, Aggarwal R, Singh U, Kakkar N, Bansal D. HPV-16 Detected in One-Fourth Eyes With Retinoblastoma: A Prospective Case-control Study From North India. J Pediatr Hematol Oncol. 2016;38:367-71.
Iron deficiency anemia

  1. *Bansal D, Jain R. Cooking in Iron Pots for Iron Deficiency Anemia: The Traditional Way Forward? Indian J Pediatr.2018;85:605-606.
  2. Krishnaswamy S, Bhattarai D, Bharti B, Bhatia P, Das R, *Bansal D. Iron Deficiency and Iron Deficiency Anemia in 3-5 months-old, Breastfed Healthy Infants. Indian J Pediatr. 2017; 84: 505–508.
  3. Bhatia P, Singh A, Hegde A, Jain R, Bansal D. Systematic evaluation of paediatric cohort with iron refractory iron deficiency anaemia (IRIDA) phenotype reveals multiple TMPRSS6 gene variations. Br J Haematol. 2017 Feb 7. [Epub ahead ofprint]
  4. Bansal D. Iron Deficiency in India. Indian J Pediatr 2016;83:615-6.
  5. Gupta SK, *Bansal D, Malhi P, Das R. Developmental profile in children with iron deficiency anemia and its changes after therapeutic iron supplementation. Indian J Pediatr 2010;77:375-9.
  6. Bansal D, Trehan A, Gupta MK, Varma N, Marwaha RK. Serodiagnosis of celiac disease in children referred for evaluation ofanemia: A Pediatric Hematology unitÂ’s experience. Indian J Pathol Microbiol 2011;54:756-60.
  7. Datta S, Bansal D, Garg P. Early versus Late Prophylactic Iron Supplementation in VLBW Infants: A Randomized Controlled Trial: Hematologists Viewpoint. Indian Pediatr. 2014;51:307-8.
  8. Rath S, Bansal D, Marwaha RK. Celiac disease: presenting with intracranial bleed and ecchymoses. J Pediat Hemat Oncol 2003; 25: 589-591.
Bone marrow failure

  1. Chhabra P, Bhatia P, Singh M, Bansal D, Jain R, Varma N, Trehan A. Pediatric bone marrow failure:Clinical, hematological and targeted next generation sequencing data. Blood Cells Mol Dis. 2020 Nov 5;87:102510.

  2. Jain R, Trehan A, Bansal D,Varma N. Aplastic anemia in children: How good is immunosuppressive therapy? Pediatr Hematol Oncol. 2019;36:211-221.

  3. Sreedharanunni S, Varma N,Sachdeva MUS, Naseem S, Malhotra P, Bansal D, Sood A, Bose P, Varma S. Paroxysmalnocturnal hemoglobinuria clones are not infrequent in patients with inherited bone marrow failure syndromes. Eur J Haematol. 2017; 99:194-195.

  4. Sreedharanunni S, Sachdeva MU, Bose P, Varma N, Bansal D, Trehan A. Frequency of paroxysmal nocturnal hemoglobinuria clones by multiparametric flow cytometry in pediatric aplastic anemia patients of Indian ethnic origin. Pediatr Blood Cancer. 2016;63:93-7.

  5. Oberoi S, *Bansal D. Good Outcome with ATG in Aplastic Anemia: Welcome News, Though Thought-provoking! Indian Pediatr 2012;49:839-40.
  6. Oberoi S, *Bansal D, Sharma RR, GautamV, Marwaha N, Marwaha RK. Antithymocyte globulin induced acute lung injury during transplant for aplastic anemia. J Pediatr Hematol Oncol 2011;33:150-2.
  7. Jha AK, *Bansal D, Sharda S, Ray P, Steele L, Varma N, Saxena AK, Marwaha RK. Shwachman-Diamond syndrome in India. Pediatr Blood Cancer 2012;58:479-80.
  8. Gupta A, Bansal D, Marwaha RK, Trehan A. Hepatitis-associated aplastic anemia: successful outcome following immunosuppressive therapy. Indian J Gastroenterol 2005; 24: 175-6.
  9. Marwaha RK, Bansal D, Trehan A, Varma N. Androgens in childhood acquired aplastic anaemia in Chandigarh, India. Trop Doct 2004; 34:149-52.
  10. Marwaha RK, Bansal D, Trehan A. Clinico-haematological profile of pure red cell aplasia in children. J Trop Pediatr 2002; 48: 113-116.
  11. Varma N, Varma S, Marwaha RK, MalhotraP, Bansal D, Malik K, Kaur S,Garewal G. Multiple constitutional aetiological factors in bone marrow failure syndrome (BMFS) patients from north India. Indian J Med Res 2006;124:51-6.

Infections, febrile neutropenia

  1. Suthar R, *Bansal D, Suri D, Sharma P, Ray P. Bone marrow granuloma in a child with pyrexia of unknown origin: A clue for diagnosis of brucellosis. Indian J Pathol Microbiol 2019; 62:493-4.
  2. Totadri S, *Bansal D. Invasive Fungal Disease in Children with Acute Leukemia: The Elusive Culprit. Indian J Pediatr. 2018;85:1059-1060.
  3. Das A, Trehan A, Bansal D. Risk Factors for Microbiologically-documented Infections, Mortality and Prolonged Hospital Stay in Children with Febrile Neutropenia. Indian Pediatr. 2018; 55:859-864.
  4. Das A, Oberoi S, Trehan A, Chakrabarti A, Bansal D, Saxena AK, Sodhi KS, Kakkar N, Srinivasan R. Invasive Fungal Disease in Pediatric Acute Leukemia in the Nontransplant Setting: 8 Years' Experience From a Tertiary Care Center in North India. J Pediatr Hematol Oncol. 2018;40:462-467.
  5. Oberoi S, Das A, Trehan A, Ray P, Bansal D. Can complications in febrile neutropenia be predicted? Report from a developing country. Support Care Cancer. 2017; 25: 3523-3528.
  6. Das A, Trehan A, Oberoi S, Bansal D. Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India. Pediatr Blood Cancer. 2016 Nov 15. doi: 10.1002/pbc.26333.
  7. Das A, Trehan A, Duseja AK, Bansal D. High Seroprevalence of Hepatitis B in Children with Cancer in India is Not Related to Transfusions or Hospital Admissions. Pediatr Blood Cancer. 2016;63:1680-1.
  8. Jain R, Trehan A, Mishra B, Singh R, Saud B, Bansal D. Cytomegalovirus disease in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol.2016;33:239-47.
  9. Trehan A, Totadri S, Gautam V, Bansal D, Ray P. Invasive bacterial infections in a pediatric oncology unit in a tertiary care center. Indian J Cancer 2014;51:428-31.
  10. Sodhi KS, Khandelwal N, Saxena AK, Bhatia A, Bansal D, Trehan A, Singh M, Agarwal R. Rapid lung MRI: Paradigm shift in evaluation of febrile neutropenia in children with leukemia: A pilot study. Leuk Lymphoma 2016;57:70-5.
  11. Bansal D, Gautam P, Dubey ML, Marwaha RK. Presumptive treatment for malaria is not justified in children receiving cancer chemotherapy. Pediatr Blood Cancer 2010;55:1108-10.
  12. Jha AK, *Bansal D, Chakrabarti A, Shivaprakash MR, Trehan A, Marwaha RK. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies. Mycoses 2013;56:442-8.
  13. Aggarwal R, *Bansal D, Naru J, Salaria M, Rana A, Minz RW, Trehan A, Marwaha RK. HSV-1 as well as HSV-2 is frequent in oral mucosal lesions of children on chemotherapy. Support Care Cancer. 2014;22:1773-9.
  14. Aggarwal R, *Bansal D, Bansal F, Nanda N, Ray P, Trehan A, Marwaha RK. Interleukin-5, interleukin-6,interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia. Indian J Med Microbiol 2013;31:226-9.
  15. Oberoi S, Suthar R, *Bansal D, Marwaha RK. Febrile Neutropenia: Outline of Management. Indian J Pediatr 2013;80:138-43.
  16. Oberoi S, Trehan A, Marwaha RK, Bansal D. Symptom to door interval in febrile neutropenia: perspective in India. Support Care Cancer 2013;21:1321-7.
  17. Gautam V, Arora A, Madhup SK, Das A, Vandamme P, Sharma K, Koushal V, Bansal D, Sharma M, Garg RK, Rana S, Marwaha RK, Ray P. Burkholderia cepacia complex in septicaemic non-cysticfibrosis cases from two tertiary care hospitals in north India. Indian J Med Res 2010;131:829-32.
  18. Bansal D, Singhi PD, Ray M, Paramjeet. Cervical intramedullary tuberculoma: Acute presentation and rapid response to medical therapy. J Trop Pediatr 2002; 48: 55-57.
Supportive care

  1. Verma S, *Bansal D. Immunization Guidelines for Children with Cancer in India. Indian Pediatr. 2019;56:1009-1010.
  2. Jain R, *Bansal D, Marwaha RK. Hyperleukocytosis: Emergency Management. Indian J Pediatr 2013;80:144-8.
  3. Bansal D, Jain R. Hyperleukocytosis: Emergency Management: Authors' Reply. Indian J Pediatr 2014;81:323.
  4. Jain R, Bansal D, Marwaha RK, Singhi S. Superior Mediastinal Syndrome: Emergency Management. Indian J Pediatr 2013;80:55-9.
  5. Rajendran A, Bansal D, Marwaha RK, Singhi SC. Tumor Lysis Syndrome. Indian J Pediatr 2013;80:50-4.
  6. Gupta A, *Bansal D, Dass R, Das A. Transfusion associated graft versus host disease. Indian Pediatr 2004;41:1260-4.
  7. Bansal D, Marwaha RK. Transfusion Reactions. Indian J Pediatr 2001; 68: 133-139.
Miscellaneous

  1. Sharma R, Jamwal M, Senee HK, Uppal V, Hira JK,  Bose P, Kumar N, Bansal D, Trehan A,  Malhotra P, Ahluwalia J, Das R. Next-Generation Sequencing Based Approach to Identify Underlying Genetic Defects of Glanzmann Thrombasthenia. Indian J Hematol Blood Transfus (2020).https://doi.org/10.1007/s12288-020-01368-8
  2. Trehan A, Jain R, Bansal D. Oncology care in a lower middle-income country during the COVID-19 pandemic. Pediatr Blood Cancer. 2020;67:e28438.

  3. Bansal D, Davidson A, Supriyadi E,Njuguna F, Ribeiro RC, Kaspers GJL. SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings. Pediatr Blood Cancer. 2019 Nov 27:e28087.

  4. Jamwal M, Aggarwal A, Sharma P, Bansal D, Trehan A, Maitra A, Das R. First report of homocystinuria-megaloblasticanaemia, cobalamin E complementation type, in an Indian child. Pathology. 2019;51:95-98.

  5. Sreedharanunni S, Varma N, Sachdeva MUS,Naseem S, Malhotra P, Bansal D, Trehan A, Varma S. The Spectrum of Hypereosinophilia and Associated Clonal Disorders - A Real-World Data Based on Combined Retrospective and Prospective Analysis from a Tropical Setting. Mediterr J Hematol Infect Dis. 2018 Sep 1;10(1):e2018052.

  6. Totadri S, *Bansal D. Addressing Psychosocial Support in Children with Cancer in Low- and Middle-Income Countries. Indian J Pediatr. 2019;86:105-106.

  7. Suri D, Bhattad S, Gupta A, Trehan A, Bansal D, Rajwanshi A, Das A, Rawat A, Singh S. Malignancies in Children with Human Immunodeficiency Virus Infection - Our Experience at Chandigarh, North India. J Trop Pediatr. 2016 Oct 22. [Epub ahead of print]

  8. Das A, *Bansal D, Chatterjee D, Das A. Kaposiform Hemangioendothelioma: Multifocal Involvement, Chylothorax, and Kasabach-Merritt Phenomenon. J Pediatr Hematol Oncol. 2017;39(2):153-154.
  9. Bansal D*. Audit of Pediatric Transfusion Practices in a Tertiary Care Hospital: Expert's Opinion. Indian J Pediatr. 2016;83:1061-2.
  10. Gupta P, Gupta N, Bansal D, Kaur R, Das A.Paediatric cutaneous reticulohistiocytoma: a diagnostic challenge on fine needle aspiration. Cytopathology. 2015;26:393-5.
  11. Goel R, Shukla J, Bansal D, Sodhi K, Bhattacharya A,Marwaha RK, Mittal BR. (68) Ga-DOTATATE positron emission tomography/computedtomography scan in the detection of bone metastases in pediatric neuroendocrine tumors. Indian J Nucl Med. 2014;29:13-7.
  12. Bansal D, Totadri S. Common Hematological Disorders in Children. Indian J Pediatr 2014;81:42-50.
  13. Bharti S, Bhatia P, Bansal D, Varma N. The accelerated phase of chediak-higashi syndrome: the importance of hematological evaluation. Turk J Haematol 2013;30:85-7.
  14. Bansal D, Patwari AK, Logani KB, Malhotra VL, Anand VK. Study of diagnostic modalities and pathology of Helicobacter pylori infection in children. Indian J Pathol Microbiol 1999;42:311-315.
  15. Bansal D, Patwari AK, Malhotra VL, Malhotra V, Anand VK. Helicobacter pylori infection in recurrent abdominal pain. Indian Pediatr 1998; 35: 329-355.
  16. Bansal D, Patwari AK, Logani KB, Jain R, Anand VK. Congenital hepatic fibrosis. Indian Pediatr 1998; 35: 170-172.